Pershing Square Capital Management, L.P., Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 6,953,380 shares at $14.85 ($103.3M) on 2016-12-12, disclosed to the SEC on 2016-12-13.
Open-market sale of $103.3M VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.85 | 3,476,690 | $51.6M | 50.0% |
| 2 | $14.85 | 3,476,690 | $51.6M | 50.0% |
| Total | $14.85 avg | 6,953,380 | $103.3M | 100% |
| Filing → |
| HHH | BUY | 2023-11-22 | $20.2M | — | Filing → |
| HHH | BUY | 2023-11-14 | $22.9M | — | Filing → |
| HHH | BUY | 2023-11-06 | $17.2M | — | Filing → |